1. Home
  2. TYRA vs SKYT Comparison

TYRA vs SKYT Comparison

Compare TYRA & SKYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TYRA
  • SKYT
  • Stock Information
  • Founded
  • TYRA 2018
  • SKYT 1991
  • Country
  • TYRA United States
  • SKYT United States
  • Employees
  • TYRA N/A
  • SKYT N/A
  • Industry
  • TYRA Biotechnology: Pharmaceutical Preparations
  • SKYT Semiconductors
  • Sector
  • TYRA Health Care
  • SKYT Technology
  • Exchange
  • TYRA Nasdaq
  • SKYT Nasdaq
  • Market Cap
  • TYRA 681.7M
  • SKYT 578.1M
  • IPO Year
  • TYRA 2021
  • SKYT 2021
  • Fundamental
  • Price
  • TYRA $13.39
  • SKYT $19.21
  • Analyst Decision
  • TYRA Strong Buy
  • SKYT Strong Buy
  • Analyst Count
  • TYRA 7
  • SKYT 3
  • Target Price
  • TYRA $30.71
  • SKYT $12.67
  • AVG Volume (30 Days)
  • TYRA 185.2K
  • SKYT 2.2M
  • Earning Date
  • TYRA 11-06-2025
  • SKYT 11-06-2025
  • Dividend Yield
  • TYRA N/A
  • SKYT N/A
  • EPS Growth
  • TYRA N/A
  • SKYT N/A
  • EPS
  • TYRA N/A
  • SKYT N/A
  • Revenue
  • TYRA N/A
  • SKYT $289,663,000.00
  • Revenue This Year
  • TYRA N/A
  • SKYT $24.47
  • Revenue Next Year
  • TYRA N/A
  • SKYT $44.03
  • P/E Ratio
  • TYRA N/A
  • SKYT N/A
  • Revenue Growth
  • TYRA N/A
  • SKYT N/A
  • 52 Week Low
  • TYRA $6.42
  • SKYT $5.67
  • 52 Week High
  • TYRA $29.60
  • SKYT $20.85
  • Technical
  • Relative Strength Index (RSI)
  • TYRA 59.58
  • SKYT 70.06
  • Support Level
  • TYRA $12.98
  • SKYT $17.74
  • Resistance Level
  • TYRA $13.92
  • SKYT $20.85
  • Average True Range (ATR)
  • TYRA 0.62
  • SKYT 1.57
  • MACD
  • TYRA 0.00
  • SKYT 0.29
  • Stochastic Oscillator
  • TYRA 55.66
  • SKYT 77.30

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About SKYT SkyWater Technology Inc.

SkyWater Technology Inc is a U.S.-based, independent, pure-play technology foundry that offers semiconductor development and manufacturing services from its fabrication facilities. In its technology as a service model, it leverages a foundation of proprietary technology, engineering to co-develop process technology intellectual property (IP) with its customers that enable disruptive concepts through its Technology Services for diverse microelectronics (integrated circuits) and related micro- and nanotechnology applications. It focuses on serving diversified, high-growth, end users in numerous vertical markets, including computation, aerospace and defense (A&D), automotive and transportation, bio-health, and industrial.

Share on Social Networks: